HOECHST ROUSSEL PHARMACEUTICALS
Similar Organizations
Whitehouse Laboratories
Whitehouse Laboratories is a fully accredited, contract testing facility.
More informations about "Hoechst Roussel Pharmaceuticals"
Roussel Uclaf -- Company History
At the same time, Hoechst benefitted from Roussel's research in agricultural products and the French company continued to benefit from their partner's marketing organization.See details»
Roussel Uclaf - Wikipedia
Roussel Uclaf S.A. was a French pharmaceutical company and one of several predecessor companies of today's Sanofi. It was the second largest French pharmaceutical company before it was acquired by Hoechst AG of Frankfurt, Germany in 1997, with pharmaceutical operations combined into the Hoechst Marion Roussel (HMR) division in the U…See details»
Hoechst Roussel Pharmaceuticals - Crunchbase
Who are Hoechst Roussel Pharmaceuticals's competitors? Alternatives and possible competitors to Hoechst Roussel Pharmaceuticals may include Whitehouse Laboratories, Magainin …See details»
Hoechst Aktiengesellschaft | Chemical production, …
Another major subsidiary, Hoechst Marion Roussel, was founded through the acquisition of American pharmaceutical firm Marion Merrell Dow Inc., which Hoechst bought in 1995, and the French drug maker Roussel Uclaf, which …See details»
Roussel Uclaf - Encyclopedia.com
May 18, 2018 At the same time, Hoechst benefitted from Roussel ’ s research in agricultural products and the French company continued to benefit from their partner ’ s marketing …See details»
"Hoechst Marion Roussel" - The New Merged Company
May 7, 1995 Headed By Godard And Markham Following the completion of the acquisition, Hoechst (which already controls the French group Roussel Uclaf) will conduct its global …See details»
The merger of Hoechst and Rhône-Poulenc to form Aventis The …
In a 1995 bid to re-establish itself as a leading player in the drug business, the com- pany acquired American pharmaceutical company Marion Merrell Dow for $7.1 billion to form …See details»
In Brief: Hoechst Marion Roussel - HBW Insight
Dec 23, 1996 Hoechst Marion Roussel: Richard Markham, 46, will succeed Jean-Pierre Godard, 58, as CEO of HMR on Jan. 1. Godard will remain head of Roussel Uclaf, Hoechst's French …See details»
Hoechst Marion Roussel - Crunchbase Company Profile …
Hoechst Marion Roussel discovers, develops, manufactures, and sells proprietary and generic pharmaceutical products.See details»
Hoechst Marion Roussel Inc. – Biopharma
Description formerly Hoechst-Roussel Pharmaceuticals, Inc.; merged into Aventis Pharma in December 1999See details»
Hoechst Marion Roussel, Inc. - Drug pipelines, Patents, Clinical …
He began his career in R&D roles at Roussel Uclaf and Hoechst Marion Roussel, pharmaceutical companies that were predecessors to today’s Sanofi. Mr.See details»
Roussel Uclaf Consolidating In Hoechst Marion Roussel
Jun 9, 1996 Roussel Uclaf of France had a "wholly satisfactory" performance in 1995, said Jean-Pierre Godard, chairman of the company, the future of which is now intrinsically linked to the …See details»
Investors - Sanofi
Sanofi India Limited is one of the entities through which Sanofi operates in India. It was incorporated in May 1956 under the name Hoechst Fedco Pharma Private Limited. Over the …See details»
In Brief: Hoechst/Roussel Uclaf - insights.citeline.com
Dec 16, 1996 Hoechst/Roussel Uclaf: Hoechst makes $3.6 bil. tender offer to acquire the 43.5%, or 11.8 mil. shares, of Roussel Uclaf it does not already own. The $293.90 per share offer …See details»
Hoechst-Roussel Pharmaceuticals, Inc.: Drug pipelines, Patents ...
Jul 22, 2023 Explore Hoechst-Roussel Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 108 literature.See details»
HOECHST BUILDS US NEURO CENTER - Pharmaceutical industry …
Jan 4, 1993 Hoechst-Roussel Pharmaceuticals, the US pharmaceutical arm of the German chemical and pharmaceutical company Hoechst, is building a center for molecular …See details»
Multinational pharmaceutical maker designs standards
May 31, 1998 The company, Hoechst Marion Roussel, is the result of the merger of the pharmaceutical operations of Hoechst AG in Frankfurt am Main, Germany; Marion Merrill Dow …See details»
Hoechst-Roussel Pharmaceuticals
Oct 3, 1994 Jean-Francois Labbe named president effective Jan. 1. Labbe will replace Jack Herdklotz, who is retiring. Labbe, currently general manager of Roussel Labs in the U.K., will …See details»
Hoechst Marion Roussel Merger Finalized In France
Oct 5, 1997 Effective October 1, Hoechst Marion Roussel in France has beenofficially formed. This is the final step in rationalizing the legal structures of the group in France, following the …See details»
Hoechst Marion Roussel Begins To Take Shape - Pharmaceutical …
Sep 24, 1995 With the receipt of final approval from the US Federal Trade Commission on September 18, the proposed combination of Hoechst's pharmaceutical business with that of …See details»